Angiogenesis and Immunity in Renal Carcinoma: Can We Turn an Unhappy Relationship into a Happy Marriage?

The frontline treatment options for patients with metastatic renal cell carcinoma (mRCC) are evolving rapidly since the approval of combination immunotherapies by the U.S. Food and Drug Administration (USFDA) and the European Medicines Agency (EMA). In particular, in combination with vascular endoth...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Med
Hlavní autoři: Mennitto, Alessia, Huber, Veronica, Ratta, Raffaele, Sepe, Pierangela, de Braud, Filippo, Procopio, Giuseppe, Guadalupi, Valentina, Claps, Mélanie, Stellato, Marco, Daveri, Elena, Rivoltini, Licia, Verzoni, Elena
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2020
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7231111/
https://ncbi.nlm.nih.gov/pubmed/32231117
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9040930
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky